2nd APEC Policy Dialogue on "Innovative Immunization Solutions to Achieve Universal Health Coverage and Improve Health System Resilience"

6 March 2025

3-5 PM KST

Lahan Select, Sirius Hall

Gyeongju, Republic of Korea & Microsoft Teams

See agenda below 

This APEC Policy Dialogue aims to enhance understanding of prophylactic monoclonal antibodies (mAbs) and their role in routine immunization; showcase successful implementation of mAbs into immunization programs; and spotlight the prevention of RSV in infants as a case study.

Building on the 1st APEC Policy Dialogue (Sep 2024), this 2nd APEC Policy Dialogue will highlight the specific models, activities, and strategies necessary for the successful introduction and scale-up of prophylactic mAbs.

Your participation will enrich discussions and contribute to actionable recommendations for member economies on issues such as: 

Access models to enable high coverage rates and sustainable access for prophylactic mAbs with case studies, such as Australia, Chile, the United States, France, Germany, and Spain 

Multistakeholder activities to prepare for launch of prophylactic mAbs, such as aligning on clinical guidelines for use by medical associations, regulators, and policymakers 

Strategies for implementation, such as management of adverse event reporting, collection and use of real-world evidence, and training of healthcare professionals

Agenda

  • Honorable Baek Jong-hean, Member of the National Assembly, Republic of Korea

  • Dr. Rafael Araos Bralic, Physician & Research Professor, Universidad de Desarrollo; Former Head, Department of Epidemiology, Ministry of Health, Chile

    Prof. Terry Nolan, AO, Pediatrician & Clinical Epidemiologist, University of Melbourne; Former Chair, Australian Technical Advisory Group on Immunisation

    Dr. Martin Terhardt, Pediatrician & Former Member, Standing Committee on Vaccination (STIKO), Robert Koch Institute, Germany

    Dr. José Navarro-Alonso, Pediatrician & Honorary Consultant, Immunization, Ministry of Health, Spain

    Dr. Todd Wolynn, Pediatrician and Executive Director, Trusted Messenger Program, a part of the Public Goods Projects, the United States of America

  • Participating economies will be invited to share challenges and successes introducing mAbs into immunization or other programs. Economies are encouraged to keep their interventions to 3 minutes or shorter.

  • Dr. Victor Melt Campos, Chair, APEC Health Working Group; Director-General, Office of International Technical Cooperation, Ministry of Health, Peru

Disclaimer: This project is a self-funded initiative by the proposing APEC economy, Chile, with the support of co-sponsoring economies. APEC does not provide funding for this project and will not be responsible for any financial, legal, or other liabilities that may arise in relation to this project, including but not limited to those concerning the use, distribution, or administration of vaccines or prophylactic treatments discussed or promoted within the scope of this project. The responsibility for the outcomes and impacts of this project lies solely with the proposing economy and its collaborators.